Artículos de revistas sobre el tema "Minimal pharmacophores"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Minimal pharmacophores".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Mortier, Jérémie, Pratik Dhakal y Andrea Volkamer. "Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces". Molecules 23, n.º 8 (6 de agosto de 2018): 1959. http://dx.doi.org/10.3390/molecules23081959.
Texto completoPetrikaite, Vilma, Eduardas Tarasevišius y Alvydas Pavilonis. "New ethacridine derivatives as the potential antifungal and antibacterial preparations". Medicina 43, n.º 8 (11 de agosto de 2007): 657. http://dx.doi.org/10.3390/medicina43080084.
Texto completoSpasov, Alexander, Irina Ovchinnikova, Olga Fedorova, Yulia Titova, Denis Babkov, Vadim Kosolapov, Alexander Borisov et al. "Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury". Molecules 28, n.º 2 (11 de enero de 2023): 741. http://dx.doi.org/10.3390/molecules28020741.
Texto completoMishra, Pranjali, Muskan Srivastav, Yashveer Gautam, Monal Singh, Neeraj Verma, Deepak S. Kapkoti, Shailendra P. Singh, Anil K. Singh y Devendra P. Rao. "A REVIEW IN CURCUMINOIDS: CHEMISTRY, ANTICANCER ACTIVITY AND FUTURE PROSPECTS". INDIAN DRUGS 61, n.º 05 (28 de mayo de 2024): 7–23. http://dx.doi.org/10.53879/id.61.05.14041.
Texto completoMaatuf, Yossi, Matan Geron y Avi Priel. "The Role of Toxins in the Pursuit for Novel Analgesics". Toxins 11, n.º 2 (23 de febrero de 2019): 131. http://dx.doi.org/10.3390/toxins11020131.
Texto completoWermelinger, Guilherme Freimann, Lucas Rubini, Anna Carolina Carvalho da Fonseca, Gabriel Ouverney, Rafael P. R. F. de Oliveira, Acácio S. de Souza, Luana S. M. Forezi, Gabriel Limaverde-Sousa, Sergio Pinheiro y Bruno Kaufmann Robbs. "A Novel MDM2-Binding Chalcone Induces Apoptosis of Oral Squamous Cell Carcinoma". Biomedicines 11, n.º 6 (14 de junio de 2023): 1711. http://dx.doi.org/10.3390/biomedicines11061711.
Texto completoBourne, Yves, Gerlind Sulzenbacher, Laurent Chabaud, Rómulo Aráoz, Zoran Radić, Sandrine Conrod, Palmer Taylor, Catherine Guillou, Jordi Molgó y Pascale Marchot. "The Cyclic Imine Core Common to the Marine Macrocyclic Toxins Is Sufficient to Dictate Nicotinic Acetylcholine Receptor Antagonism". Marine Drugs 22, n.º 4 (27 de marzo de 2024): 149. http://dx.doi.org/10.3390/md22040149.
Texto completoCaldas Lopes, Eloisi, Shieh Jae-Hung, Srikanth Ambati, Su Tsann-Long, Fabian Correa, Elizabeth Peguero y Malcolm A. S. Moore. "Novel Alkylating Agent, Ureidomustine Exhibit Pre-Clinical Efficacy in B-Cell Lymphoma with Minimal Dose-Limiting Myelotoxicity". Blood 126, n.º 23 (3 de diciembre de 2015): 1556. http://dx.doi.org/10.1182/blood.v126.23.1556.1556.
Texto completoVawhal, Pallavi Kishor, Shailaja B. Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L. Khan et al. "Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay". Molecules 28, n.º 3 (19 de enero de 2023): 1004. http://dx.doi.org/10.3390/molecules28031004.
Texto completoRobertson, Gregory T., Eric J. Bonventre, Timothy B. Doyle, Qun Du, Leonard Duncan, Timothy W. Morris, Eric D. Roche, Dalai Yan y A. Simon Lynch. "In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci". Antimicrobial Agents and Chemotherapy 52, n.º 7 (julio de 2008): 2324–34. http://dx.doi.org/10.1128/aac.01651-07.
Texto completoCheng, Jeffrey, Enming Xing, Shabber Mohammed, Emma Montgomery, Lauren Granchie, Christopher Coss y Pui-Kai Li. "Abstract 3106: Design, synthesis, and screening of niclosamide analogs as androgen receptor degraders for hepatocellular carcinoma". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3106. http://dx.doi.org/10.1158/1538-7445.am2023-3106.
Texto completoAlhadrami, Hani A., Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy y Mostafa E. Rateb. "Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor". Pharmaceuticals 14, n.º 6 (5 de junio de 2021): 541. http://dx.doi.org/10.3390/ph14060541.
Texto completoOsborne, Joseph, Naveed Hassan Akhtar, Shankar Vallabhajosula, Anastasia Nikolopoulou, Kevin P. Maresca, Shawn M. Hillier, John L. Joyal et al. "Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC)." Journal of Clinical Oncology 30, n.º 5_suppl (10 de febrero de 2012): 173. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.173.
Texto completoHall, Ronald G., Jotam Pasipanodya, William C. Putnam, John Griswold, Sharmila Dissanaike, Raja Reddy Kallem, Vindhya Edpuganti y Indhumathy Subramaniyan. "1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns". Open Forum Infectious Diseases 7, Supplement_1 (1 de octubre de 2020): S670—S671. http://dx.doi.org/10.1093/ofid/ofaa439.1501.
Texto completoSchlitzer, Martin, Labaniel Rodriguez y Peter F. Kador. "Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements". Journal of Pharmacy and Pharmacology 53, n.º 6 (junio de 2001): 831–39. http://dx.doi.org/10.1211/0022357011776180.
Texto completoPapke, Roger L., Kinga Chojnacka y Nicole A. Horenstein. "The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor". Journal of Pharmacology and Experimental Therapeutics 350, n.º 3 (2 de julio de 2014): 665–80. http://dx.doi.org/10.1124/jpet.114.215236.
Texto completoMagnin, David R., Prakash C. Taunk, James G. Robertson, Aiying Wang, Jovita Marcinkeviciene, Mark S. Kirby y Lawrence G. Hamann. "Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1". Bioorganic & Medicinal Chemistry Letters 16, n.º 6 (marzo de 2006): 1731–34. http://dx.doi.org/10.1016/j.bmcl.2005.11.098.
Texto completoJohnston, Alexis y Adegboyega K. Oyelere. "Abstract 4492: Deferiprone optimization for the treatment of triple-negative breast cancer". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 4492. http://dx.doi.org/10.1158/1538-7445.am2024-4492.
Texto completoCruz, María del Carmen, María Salazar, Yésica Garciafigueroa, Dolores Hernández, Francisco Díaz, Germán Chamorro y Joaquín Tamariz. "Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α-Asarone with Minimal Pharmacophore Features". Drug Development Research 60, n.º 3 (3 de octubre de 2003): 186–95. http://dx.doi.org/10.1002/ddr.10281.
Texto completoBjij, Imane, Pritika Ramharack, Shama Khan, Driss Cherqaoui y Mahmoud E. S. Soliman. "Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling". Molecules 24, n.º 17 (28 de agosto de 2019): 3125. http://dx.doi.org/10.3390/molecules24173125.
Texto completoWood, Daniel J., J. Daniel Lopez-Fernandez, Leanne E. Knight, Islam Al-Khawaldeh, Conghao Gai, Shengying Lin, Mathew P. Martin et al. "FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation". Journal of Medicinal Chemistry 62, n.º 7 (12 de marzo de 2019): 3741–52. http://dx.doi.org/10.1021/acs.jmedchem.9b00304.
Texto completoOstash, Bohdan, Emma Doud y Victor Fedorenko. "The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases". Biological Chemistry 391, n.º 5 (1 de mayo de 2010): 499–504. http://dx.doi.org/10.1515/bc.2010.053.
Texto completoGozalbes, Rafael, Silvia Mosulén, Rodrigo J. Carbajo y Antonio Pineda-Lucena. "Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors". Journal of Computer-Aided Molecular Design 23, n.º 8 (7 de mayo de 2009): 555–69. http://dx.doi.org/10.1007/s10822-009-9269-0.
Texto completoLadouceur, Gaétan, Dale E. Mais, Joseph A. Jakubowski, Barbara G. Utterback y David W. Robertson. "Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptors". Bioorganic & Medicinal Chemistry Letters 1, n.º 3 (enero de 1991): 173–78. http://dx.doi.org/10.1016/s0960-894x(01)80794-0.
Texto completoMittal, Ravi K. y Priyank Purohit. "Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent". Anti-Cancer Agents in Medicinal Chemistry 20, n.º 16 (5 de noviembre de 2020): 1981–91. http://dx.doi.org/10.2174/1871520620666200619175906.
Texto completoKhomutov, Maxim A., Fabio Giovannercole, Laura Onillon, Marija V. Demiankova, Byazilya F. Vasilieva, Arthur I. Salikhov, Sergey N. Kochetkov, Olga V. Efremenkova, Alex R. Khomutov y Daniela De Biase. "A Desmethylphosphinothricin Dipeptide Derivative Effectively Inhibits Escherichia coli and Bacillus subtilis Growth". Biomolecules 13, n.º 10 (26 de septiembre de 2023): 1451. http://dx.doi.org/10.3390/biom13101451.
Texto completoDemeter, David A., Herschel J. R. Weintraub y James J. Knittel. "The Local Minima Method (LMM) of Pharmacophore Determination: A Protocol for Predicting the Bioactive Conformation of Small, Conformationally Flexible Molecules". Journal of Chemical Information and Computer Sciences 38, n.º 6 (noviembre de 1998): 1125–36. http://dx.doi.org/10.1021/ci980404z.
Texto completoJi, Haitao, Benjamin Z. Stanton, Jotaro Igarashi, Huiying Li, Pavel Martásek, Linda J. Roman, Thomas L. Poulos y Richard B. Silverman. "Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors". Journal of the American Chemical Society 130, n.º 12 (marzo de 2008): 3900–3914. http://dx.doi.org/10.1021/ja0772041.
Texto completoRasaeifar, Bahareh, Patricia Gomez-Gutierrez y Juan J. Perez. "New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding". Pharmaceuticals 13, n.º 8 (17 de agosto de 2020): 197. http://dx.doi.org/10.3390/ph13080197.
Texto completoMartinenghi, Laura Daniela, Rie Jønsson, Torben Lund y Håvard Jenssen. "Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L." Biomolecules 10, n.º 6 (12 de junio de 2020): 900. http://dx.doi.org/10.3390/biom10060900.
Texto completoEzekiel, Olugbogi A., Arobadade A. Oluwaotbiloba, Balogun A. Samuel, Adelakun G. Oluwatosin, Maduike N. Mary, Fadeju T. Rasheedat, Kayode O. Yetunde et al. "Application of In-silico Methodologies in Exploring the Antagonistic Potential of Trigonella frenum-graecum on Cyclooxygenase-2 (Cox-2) in Cancer Treatment". IPS Journal of Molecular Docking Simulations 2, n.º 1 (15 de septiembre de 2023): 26–36. http://dx.doi.org/10.54117/ijmds.v2i1.20.
Texto completoZapata-Acevedo, César A. y Paul L. A. Popelier. "The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study". Pharmaceuticals 15, n.º 10 (8 de octubre de 2022): 1237. http://dx.doi.org/10.3390/ph15101237.
Texto completoMa’arif, Burhan, Faisal Akhmal Muslikh, Luqman Alfani Najib, Ria Ramadhani Dwi Atmaja y Meilina Ratna Dianti. "In Silico Antiosteoporosis Activity of 96% Ethanol Extract of Chrysophyllum cainito L. Leaves". Proceedings of International Pharmacy Ulul Albab Conference and Seminar (PLANAR) 1 (5 de diciembre de 2021): 61. http://dx.doi.org/10.18860/planar.v1i0.1460.
Texto completoMotsilanyane, Andrew Rabontsi, Zimbili Mkhize y Sphelele Sosibo. "Computational Studies for Selected Medicinal Plants against Dolutegravir using Ligand Based Pharmacophore, Molecular Docking, ADMET Predictionsand Molecular Dynamics Simulation". Pakistan Journal of Medical and Health Sciences 16, n.º 1 (30 de enero de 2022): 927–36. http://dx.doi.org/10.53350/pjmhs22161927.
Texto completoFrancesconi, Valeria, Elena Cichero, Evgeny V. Kanov, Erik Laurini, Sabrina Pricl, Raul R. Gainetdinov y Michele Tonelli. "Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies". Pharmaceuticals 13, n.º 11 (14 de noviembre de 2020): 391. http://dx.doi.org/10.3390/ph13110391.
Texto completoMcBride, Molly J., Sarah R. Pope, Kai Hu, C. Denise Okafor, Emily P. Balskus, J. Martin Bollinger y Amie K. Boal. "Structure and assembly of the diiron cofactor in the heme-oxygenase–like domain of the N-nitrosourea–producing enzyme SznF". Proceedings of the National Academy of Sciences 118, n.º 4 (19 de enero de 2021): e2015931118. http://dx.doi.org/10.1073/pnas.2015931118.
Texto completoZhou, Heyang, Niao Yang, Wei Li, Xuemi Peng, Jiaxiao Dong, Yuanying Jiang, Lan Yan, Dazhi Zhang y Yongsheng Jin. "Exploration of Baicalein-Core Derivatives as Potent Antifungal Agents: SAR and Mechanism Insights". Molecules 28, n.º 17 (30 de agosto de 2023): 6340. http://dx.doi.org/10.3390/molecules28176340.
Texto completoHasan, Md Rifat, Ahad Amer Alsaiari, Burhan Zain Fakhurji, Mohammad Habibur Rahman Molla, Amer H. Asseri, Md Afsar Ahmed Sumon, Moon Nyeo Park, Foysal Ahammad y Bonglee Kim. "Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process". Molecules 27, n.º 13 (29 de junio de 2022): 4169. http://dx.doi.org/10.3390/molecules27134169.
Texto completoRaghuvanshi, Rinky y Sandip B. Bharate. "Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review". Current Topics in Medicinal Chemistry 20, n.º 12 (1 de junio de 2020): 1124–35. http://dx.doi.org/10.2174/1568026620666200325110444.
Texto completoHao, Wenhui, Shiying Che, Jinsheng Li, Jingyi Luo, Wanqiu Zhang, Yang Chen, Zijian Zhao, Hao Wei y Weidong Xie. "Synthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms". Molecules 27, n.º 9 (5 de mayo de 2022): 2948. http://dx.doi.org/10.3390/molecules27092948.
Texto completoTing, Jasmine U., Maria Carmen S. Tan, Vincent Antonio S. Ng, Stephani Joy Y. Macalino, Virgilio C. Linis y Glenn G. Oyong. "Molecular Simulations of Unexplored Philippine Plant Constituents on the Inhibition of the Proinflammatory Marker NF-κB p50 Subunit". Crystals 14, n.º 5 (4 de mayo de 2024): 438. http://dx.doi.org/10.3390/cryst14050438.
Texto completoBranco, Jessica R., Vanessa G. Oliveira, Amanda M. Esteves, Ingrid C. Chipoline, Miriam F. O. Lima, Fernanda C. S. Boechat, Fernando C. da Silva et al. "A Novel Naphthotriazolyl-4-oxoquinoline Derivative that Selectively Controls Breast Cancer Cells Survival Through the Induction of Apoptosis". Current Topics in Medicinal Chemistry 18, n.º 17 (26 de noviembre de 2018): 1465–74. http://dx.doi.org/10.2174/1568026618666180821142458.
Texto completoLomovskaya, Olga, Kirk J. Nelson y Debora Rubio-Aparicio. "727. Potency of the β-Lactamase Inhibitor QPX7728 Is Minimally Affected by KPC Mutations that Reduce Potency of Ceftazidime–Avibactam". Open Forum Infectious Diseases 6, Supplement_2 (octubre de 2019): S326. http://dx.doi.org/10.1093/ofid/ofz360.795.
Texto completoSokolova, K. V., V. V. Stavytskyi, S. О. Konovalova, O. A. Podpletnya, S. I. Kovalenko y A. P. Avdeenko. "Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology". Medicni perspektivi 27, n.º 4 (29 de diciembre de 2022): 27–37. http://dx.doi.org/10.26641/2307-0404.2022.4.271120.
Texto completoSacco, Antonio, Cinzia Federico, Arianna Giacomini, Cinzia Caprio, Federica Maccarinelli, Katia Todoerti, Vanessa Favasuli et al. "FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88". Blood 136, Supplement 1 (5 de noviembre de 2020): 43–44. http://dx.doi.org/10.1182/blood-2020-136523.
Texto completoLuthra, Pratibha Mehta y Nitin Kumar. "Progress and development of C-3, C-6, and N-9 position substituted carbazole integrated molecular hybrid molecules as potential anticancer agents". Mini-Reviews in Medicinal Chemistry 21 (21 de mayo de 2021). http://dx.doi.org/10.2174/1389557521666210521221808.
Texto completoWhitehouse, Rebecca L., Wesam S. Alwan, Olga V. Ilyichova, Ashley J. Taylor, Indu R. Chandrashekaran, Biswaranjan Mohanty, Bradley C. Doak y Martin J. Scanlon. "Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores". RSC Medicinal Chemistry, 2022. http://dx.doi.org/10.1039/d2md00253a.
Texto completoSingh, Shailja y Shrawan Kumar Mangawa. "Ferrocene Derivatives as New Generation of Antimalarial Agents: Opportunity or Illusion?" Current Topics in Medicinal Chemistry 23 (28 de febrero de 2023). http://dx.doi.org/10.2174/1568026623666230228153114.
Texto completoKayastha, Forum, Noah B. Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E. Kellogg y Ronald B. Gartenhaus. "Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma". Molecular Medicine 28, n.º 1 (4 de septiembre de 2022). http://dx.doi.org/10.1186/s10020-022-00534-0.
Texto completoRath, Santosh Kumar, Sudip Kumar Mandal, Agnidipta Das, Anindya Bose, Vagish Dwibedi, Paramita Ganguly, Sipra Sarkar, Ranjana Prakash, Biplab Kumar Dey y Sanjeet Mandal. "Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer". Current Cancer Therapy Reviews 19 (30 de diciembre de 2022). http://dx.doi.org/10.2174/1573394719666221230111838.
Texto completo